Literature DB >> 31363056

Adiposity is related to cerebrovascular and brain volumetry outcomes in the RUN DMC study.

Ilse A C Arnoldussen1, Deborah R Gustafson2, Esther M C Leijsen1, Frank-Erik de Leeuw1, Amanda J Kiliaan1.   

Abstract

OBJECTIVE: Adiposity predictors, body mass index (BMI), waist circumference (WC), and blood leptin and total adiponectin levels were associated with components of cerebral small vessel disease (CSVD) and brain volumetry in 503 adults with CSVD who were ≥50 years of age and enrolled in the Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Imaging Cohort (RUN DMC).
METHODS: RUN DMC participants were followed up for 9 years (2006-2015). BMI, WC, brain imaging, and dementia diagnoses were evaluated at baseline and follow-up. Adipokines were measured at baseline. Brain imaging outcomes included CSVD components, white matter hyperintensities, lacunes, microbleeds, gray and white matter, hippocampal, total brain, and intracranial volumes.
RESULTS: Cross-sectionally among men at baseline, higher BMI, WC, and leptin were associated with lower gray matter and total brain volumes, and higher BMI and WC were associated with lower hippocampal volume. At follow-up 9 years later, higher BMI was cross-sectionally associated with lower gray matter volume, and an obese WC (>102 cm) was protective for ≥1 lacune or ≥1 microbleed in men. In women, increasing BMI and overweight or obesity (BMI ≥25 kg/m2 or WC >88 cm) were associated with ≥1 lacune. Longitudinally, over 9 years, a baseline obese WC was associated with decreasing hippocampal volume, particularly in men, and increasing white matter hyperintensity volume in women and men.
CONCLUSIONS: Anthropometric and metabolic adiposity predictors were differentially associated with CSVD components and brain volumetry outcomes by sex. Higher adiposity is associated with a vascular-neurodegenerative spectrum among adults at risk for vascular forms of cognitive impairment and dementias.
© 2019 American Academy of Neurology.

Entities:  

Year:  2019        PMID: 31363056     DOI: 10.1212/WNL.0000000000008002

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Structural retinal changes in cerebral small vessel disease.

Authors:  S Magdalena Langner; Jan H Terheyden; Clara F Geerling; Christine Kindler; Vera C W Keil; Christopher A Turski; Gabrielle N Turski; Charlotte Behning; Maximilian W M Wintergerst; Gabor C Petzold; Robert P Finger
Journal:  Sci Rep       Date:  2022-06-03       Impact factor: 4.996

2.  Development of cognition decline in non-acute symptomatic patients with cerebral small vessel disease: Non-Acute Symptomatic Cerebral Ischemia Registration study (NASCIR)-rationale and protocol for a prospective multicentre observational study.

Authors:  Shuting Zhang; Zhetao Wang; Peng Liu; Qingzhang Tuo; Yajun Cheng; Mangmang Xu; Qian Wu; Peng Lei; Lunzhi Dai; William Robert Kwapong; Mingying Tan; Ming Liu
Journal:  BMJ Open       Date:  2022-02-22       Impact factor: 2.692

Review 3.  Effects of Nutrients on Platelet Function: A Modifiable Link between Metabolic Syndrome and Neurodegeneration?

Authors:  Ilse A C Arnoldussen; Renger F Witkamp
Journal:  Biomolecules       Date:  2021-10-04

4.  Body Mass Index and Leptin Are Related to Cognitive Performance Over 10 Years in Women With and Without HIV Infection.

Authors:  Francesca Macaluso; Kathleen M Weber; Leah H Rubin; Elaine Dellinger; Susan Holman; Howard Minkoff; Sheila Keating; Lisa R Merlin; Deborah R Gustafson
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

Review 5.  Gut Microbiome, Inflammation, and Cerebrovascular Function: Link Between Obesity and Cognition.

Authors:  Lisette Olsthoorn; Debby Vreeken; Amanda J Kiliaan
Journal:  Front Neurosci       Date:  2021-12-06       Impact factor: 4.677

6.  Commentary on Lahiri et al. Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV.

Authors:  Francesca Macaluso; Deborah R Gustafson
Journal:  J AIDS HIV Treat       Date:  2021
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.